Determination of Risk Factors and Awareness Associated With Development of Neuromuscular Scoliosis
NCT ID: NCT04764812
Last Updated: 2022-02-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
288 participants
OBSERVATIONAL
2021-03-01
2022-09-26
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Hip Related Functional Limitations in Individuals With Idiopathic Scoliosis
NCT04677140
The Effect of Spinal Orthosis on the Development of Scoliosis and Chest Deformity in Type I Spinal Muscular Atrophy
NCT05878418
Body Awareness and Spinal Stability in Scoliosis
NCT06347419
Reliability and Validity of Hand Dynamometer Trunk Muscle Strength Measurements in Patients With AIS
NCT06416592
Dual Task Effect in Adolescent Idiopathic Scoliosis
NCT06446986
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* receiving treatment at a rehabilitation center in Istanbul
* willing to participate in the research and permitted by their caregiver
Exclusion Criteria
* Trauma history of lower extremity
3 Years
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Medipol University
OTHER
Istanbul Rumeli University
OTHER
Halic University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Özge Ökçü, MSc.
Role: PRINCIPAL_INVESTIGATOR
Istanbul Rumeli University
Hande Tunc, MSc.
Role: PRINCIPAL_INVESTIGATOR
Halic University
Ahsen Buyukaslan, PhD.(c)
Role: PRINCIPAL_INVESTIGATOR
Medipol University
Hürriyet Yılmaz, Prof.Dr.
Role: STUDY_DIRECTOR
Halic University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Rehabilitation Center
Istanbul, İ̇stanbul, Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Özge Ökçü, PT
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HUEK96-28
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.